Clinical Trial Update: Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and efficacy of everolimus in metastatic renal cell carcinoma after failure of first-line therapy with sunitinib or pazopanib; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Metastatic Renal Cell Carcinoma (mRCC) | Phase 4 | Status: COMPLETED | Results posted: 2017-07-19